Liquidia $LQDA grew Q3 revenue to $225.3M from $54.34M a year ago, almost all from YUTREPIA (+31% vs Q2). But GAAP net loss hit $236.3M ($2.64/share) on a roug

Liquidia $LQDA grew Q3 revenue to $225.3M from $54.34M a year ago, almost all from YUTREPIA (+31% vs Q2). But GAAP net loss hit $236.3M ($2.64/share) on a roughly $389.7M litigation settlement charge with United Therapeutics. The settlement keeps YUTREPIA on the market but limits it to PAH and comm…